You are viewing: South Korea Non Invasive Prenatal Testing Market analysis

The South Korea Non Invasive Prenatal Testing Market was valued at $48.6 Million in 2024 and projected to reach to $91.2 Million by 2029, representing a compound annual growth rate of 13.4%. South Korea's NIPT market is positioned for sustained growth through 2029, supported by increasing awareness of prenatal health screening and technological innovations in genetic testing.

South Korea Non Invasive Prenatal Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Non Invasive Prenatal Testing Market Trends and Insights

  • This 13.4% compound annual growth rate reflects South Korea's advanced healthcare infrastructure, high adoption of prenatal screening technologies, and increasing maternal age among the population.
  • South Korea's strong emphasis on preventive healthcare and early disease detection has positioned the country as a leader in NIPT adoption across the Asia Pacific region. The growth trajectory in South Korea is driven by rising awareness of genetic disorders, improved accessibility to testing services, and supportive regulatory frameworks that encourage innovation in diagnostic technologies.
  • South Korea's aging demographic profile and declining birth rates have paradoxically increased the demand for advanced prenatal testing among expectant mothers seeking comprehensive fetal health assessments.
  • Healthcare providers in South Korea continue to integrate NIPT into standard prenatal care protocols, further accelerating market penetration through 2029..

Key Market Statistics

  • CAGR (2024-2029) 13.4% CAGR
  • Market Size, 2024 ~USD 48.6 Million
  • Forecast, 2029 ~USD 91.2 Million
  • Country South Korea

South Korea Non Invasive Prenatal Testing Market Overview

Rapid Market Expansion :

South Korea's NIPT market is growing at 13.4% CAGR, expanding from USD 48.6 million in 2024 to USD 91.2 million by 2029, driven by technological advancement and healthcare accessibility.

Advanced Healthcare Infrastructure :

South Korea's sophisticated medical system and high internet penetration enable widespread adoption of non-invasive prenatal testing technologies among healthcare providers and expectant mothers.

Increasing Maternal Age Trends :

Rising average maternal age in South Korea correlates with higher demand for advanced prenatal screening, as older pregnancies carry increased chromosomal abnormality risks requiring NIPT solutions.

Strong Regulatory Support :

South Korea's progressive healthcare policies and reimbursement frameworks increasingly cover NIPT procedures, making testing more accessible and affordable for the general population.

South Korea Non Invasive Prenatal Testing Market Dynamics

  • The country's aging maternal demographic and emphasis on preventive healthcare create favorable conditions for market expansion.
  • Healthcare providers are investing in advanced diagnostic capabilities, while insurance coverage improvements enhance patient accessibility.
  • South Korea's competitive healthcare landscape and strong R&D capabilities will likely drive the introduction of next-generation NIPT solutions, further accelerating market penetration and establishing the nation as a regional leader in prenatal diagnostics..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    In Vitro Diagnostics

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Dna Microarrays
    • Assay Kits
    • Microarrays
    Top Companies
    • ROCHE HOLDINGS AG
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Abbott Laboratories
    • Biomerieux s.a.

      Key Takeaways

      • South Korea's NIPT market is valued at USD 48.6 million in 2024 and will nearly double to USD 91.2 million by 2029.
      • South Korea demonstrates a 13.4% CAGR, outpacing many developed markets due to high healthcare spending and technological adoption.
      • South Korea's advanced medical infrastructure and emphasis on preventive care drive widespread NIPT integration into prenatal screening protocols.
      • South Korea's demographic trends, including advanced maternal age, create sustained demand for non-invasive genetic testing solutions.

      Non Invasive Prenatal Testing Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment CFDNA IN MATERNAL PLASMA (Method)
      Forecast Period 2024-2029
      Growth Rate CAGR of 14.5% from 2024 to 2029
      Largest Segment TRISOMY (Application)
      Market Size Base Year (Billions) ~USD 7.16 (2024)
      Revenue Forecast (Billions) ~USD 14.1 (2029)
      Segments Covered Product & Service, Type, Method, Application, End User

      South Korea Non Invasive Prenatal Testing Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Assay Kits & Reagents
      • Consumables
      • Disposables
      • Instruments
      • Microarrays
      • Ngs Systems
      • Other Instruments
      • Pcr Instruments
      • Ultrasound Devices

      By Method

      • Biochemical Screening Tests
      • Cfdna In Maternal Plasma
      • Cfdna In Maternal Plasma Tests
      • Ultrasound Detection

      By Application

      • Microdeletion Syndrome
      • Other Applications
      • Trisomy

      By End User

      • Diagnostic Laboratories
      • Hospitals

      Target Audience

      • Diagnostic Companies & NIPT Providers : Need South Korea-specific market data to assess expansion opportunities, competitive positioning, and revenue potential in this high-growth prenatal testing market.
      • Healthcare Investment Firms : Require detailed South Korea market analysis to evaluate investment opportunities in diagnostic technology companies and prenatal healthcare service providers.
      • Medical Device Manufacturers : Seek market intelligence on South Korea's NIPT adoption rates, regulatory pathways, and reimbursement structures to guide product development and commercialization strategies.
      • Healthcare Consultants & Advisors : Need comprehensive South Korea market insights to advise clients on market entry, competitive strategies, and growth opportunities in the prenatal diagnostics sector.
      • Hospital & Clinic Networks : Require market forecasts and trend analysis to make informed decisions about NIPT service offerings, technology investments, and patient care program development in South Korea.

      Reasons to Buy this Report

      • Market-Specific Growth Projections : Access detailed South Korea NIPT market forecasts through 2029, enabling accurate business planning and investment decisions tailored to this high-growth Asian market.
      • Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, key players, and market positioning strategies specific to the region's advanced healthcare ecosystem.
      • Regulatory & Reimbursement Insights : Gain critical knowledge of South Korea's healthcare policies, insurance coverage frameworks, and regulatory requirements affecting NIPT market accessibility and profitability.
      • Demographic & Trend Analysis : Leverage data on South Korea's increasing maternal age, healthcare adoption rates, and consumer preferences driving NIPT demand in this affluent market.
      • Strategic Market Entry Planning : Develop informed go-to-market strategies for South Korea with comprehensive market sizing, growth drivers, and opportunity identification for healthcare providers and diagnostic companies.

      Frequently asked questions

      What is the current market size of NIPT in South Korea?

      South Korea's NIPT market was valued at USD 48.6 million in 2024 and is expected to grow to USD 91.2 million by 2029.

      What is the projected growth rate for South Korea's NIPT market?

      South Korea's NIPT market is projected to grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2029.

      Why is South Korea's NIPT market growing faster than global averages?

      South Korea's advanced healthcare infrastructure, high maternal age, strong preventive care emphasis, and supportive regulatory environment drive faster adoption of NIPT technologies compared to global trends.

      What factors are driving NIPT adoption in South Korea?

      Key drivers in South Korea include rising awareness of genetic disorders, improved test accessibility, increasing maternal age, declining birth rates, and integration of NIPT into standard prenatal care protocols.

      How does South Korea's NIPT market compare to other Asia Pacific countries?

      South Korea leads the Asia Pacific region in NIPT adoption due to its advanced healthcare system, high per-capita healthcare spending, and strong emphasis on early disease detection and preventive medicine.

      RESEARCH METHODOLOGY

      This study involved four major activities in estimating the current non-invasive prenatal testing (NIPT) market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the non-invasive prenatal testing (NIPT) market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer non-invasive prenatal testing (NIPT) product and service. Primary sources from the demand side include industry experts such as doctors, hospital directors and managers,  and other medical professionals.

      Primary research was conducted to identify segmentation types; industry trends; technology trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, and key player strategies.

      Non-invasive Prenatal Testing Market Size, and Share

      Note 1: Others include sales, marketing, and product managers.

      Note 2: Their total revenues define the tiers of companies as of 2023, tier 1 = >USD 500 million, tier 2 = USD 200 million to USD 500 million, and tier 3 = <USD 200 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Non-invasive Prenatal Testing Market Size, and Share

      Market Size Estimation

      The total size of the non-invasive prenatal testing (NIPT) market was arrived at after data triangulation from four different approaches, as mentioned below.

      Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the medical device cleaning businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.

      Country level Analysis: The size of the non-invasive prenatal testing (NIPT) market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of non-invasive prenatal testing (NIPT) products in the overall non-invasive prenatal testing (NIPT) market was obtained from secondary data and validated by primary participants to arrive at the total non-invasive prenatal testing (NIPT) market. Primary participants further validated the numbers.

      Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

      Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

      Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

      Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

      At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall non-invasive prenatal testing (NIPT) market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

      After complete market engineering with calculations for market statistics, market size estimations, market forecasting, market breakdown, and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and further quantitative analysis was also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

      Global Non-invasive prenatal testing (NIPT) market Size: Top-Down Approach

      Non-invasive Prenatal Testing Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global Non-invasive prenatal testing (NIPT) market Size: Bottom-Up Approach

      Non-invasive Prenatal Testing Market Size, and Share

      Data Triangulation

      After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.

      Approach to derive the market size and estimate market growth

      The market rankings for leading players were ascertained after a detailed assessment of their revenues from the non-invasive prenatal testing (NIPT) business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.

      Market Definition

      Non-invasive prenatal testing (NIPT) is a method used to screen chromosomal abnormalities in a developing fetus by analyzing small fragments of fetal Cell-Free DNA circulating in a pregnant woman's blood. Non-invasive prenatal tests enable the detection of chromosomal abnormalities, such as trisomy 21 (Down Syndrome), trisomy 18 (Edwards' Syndrome), trisomy 13 (Patau Syndrome), microdeletion syndrome, and other genetic conditions. This market encompasses products such as assay kits and reagents, next generation sequencing systems, and diagnostic services offered by laboratories.

      Key Stakeholders

      • Non-invasive prenatal testing product manufacturing companies
      • Hospitals and private clinics
      • Diagnostic laboratories
      • Medical research institutes
      • Market research and consulting firms
      • Suppliers and distributors of NIPT instruments
      • Venture capitalists and investors
      • Regulatory agencies and government bodies

      Objectives of the Study

      • To define, describe, and forecast the global non-invasive prenatal testing (NIPT) market on the basis of product and service, method, application, end user, and region
      • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
      • To strategically analyze the regulatory scenario, pricing trends, value chain, supply chain, ecosystem analysis, key stakeholders and buying criteria, technology scenario, patent scenario, and key conferences and events in the market
      • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall udder health market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
      • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies.
      • To strategically analyze the udder health market in five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
      • To track and analyze competitive developments such as acquisitions, partnerships, and expansions in the udder health market.

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players

      Geographic Analysis

      • Further breakdown of the Rest of Asia Pacific non-invasive prenatal testing (NIPT) market into China, Japan, India, South Korea, and other countries.

      Get the Full Non Invasive Prenatal Testing Market Report

      Full forecast, segment splits, and company analysis for all Non Invasive Prenatal Testing Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status